SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) is experiencing an intense sell-off and community debate following the abrupt departures of its CFO and general counsel amid an ongoing accounting review, delayed regulatory filings, and reduced financial guidance. While many see the over 50% plunge as an extreme overreaction and a potential buying opportunity, others express deep concern over financial irregularities, referencing a past short report, and caution against further downside.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is generating strong community buzz as its AI-powered ecosystem expands with new exchange listings and cross-chain integrations, leading many to anticipate significant price milestones and further utility growth.

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

Satellos Bioscience (MSLE) is trending following its recent NASDAQ listing and a significant $50 million financing, sparking intense debate around its novel Duchenne Muscular Dystrophy drug, SAT-3247. The community is split between those hailing its "revolutionary" muscle regeneration potential and acquisition prospects, and skeptics citing its early-stage data and concerns over dilution.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending following its preliminary Q3 revenue exceeding expectations, sparking a surge of investor enthusiasm. The community is actively discussing the company's substantial year-over-year growth and its reinforced position as a crucial 'picks and shovels' provider for the expanding AI data center infrastructure.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as its highly dedicated community champions a "permissionless brand" model, consistently launching real-world products like KENDU SPICE, fostering strong conviction and active accumulation even amidst broader market downturns. This unique approach to building real value differentiates it as a long-term play.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors react to the inauguration of its Eagle Line pilot production facility, signaling a crucial step towards scalable solid-state battery manufacturing. The community is actively debating whether this progress, including observed OEM presence, translates to imminent commercialization and new partnerships, or if skepticism over revenue and formal customer announcements will persist ahead of upcoming earnings.

Ferrari NV is a holding company, which engages in the design, engineering, production, and sale of luxury sports cars. The firm's models include the F12Berlinetta, 488GTB, 488 Spider, 458 Speciale, California T, the LaFerrari Hybrid, LaFerrari, and the FF four-wheel drive. It participates in car racing such as Formula One. The company was founded by Enzo Anselmo Ferrari in 1939 and is headquartered in Maranello, Italy.

Ferrari N.V.

Ferrari's recent stock plunge stems from conservative long-term growth guidance and a reduced electric vehicle target, sparking debate among investors. While some fear a slower EV transition and high valuation, others see an overreaction, emphasizing the brand's unmatched luxury demand, historically conservative guidance, and active share buyback program.

NexGen Energy Ltd. engages in the acquisition, exploration and development of uranium properties. Its uranium project portfolio includes Arrow, South Arrow, Harpoon, Bow, IsoEnergy, SW1, SW2, SW3, and IsoEnergy properties. The company was founded by Leigh B. Curyer on March 8, 2011 and is headquartered in Vancouver, Canada.

NexGen Energy Ltd

NexGen Energy (NXE) is trending following a critical short report from Culper Research that challenged its valuation and production capabilities, sparking a strong defense from the community. Investors are refuting the report's claims, underscoring the company's world-class uranium deposit and its strategic role in meeting rising global nuclear and AI-driven energy demand as it approaches key regulatory milestones.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as its stock experiences a steep decline despite a recent Q4 earnings beat, prompting community concern over executive stock-based compensation and competitive pressures from rivals developing similar app features.

Syntec Optics Holdings, Inc. engages in the design and manufacture of optics and photonics enabled products. The company was founded in 1981 and is headquartered in Rochester, NY.

Syntec Optics Holdings Inc. - Ordinary Shares - Class A

Syntec Optics Holdings Inc

Syntec Optics (OPTX) is gaining traction from new ballistic optics orders for U.S. military augmented reality systems and increasing demand for its space and AI data center optics. The community is actively debating its low float and significant growth potential from defense and AI tailwinds against concerns over its current valuation and cash position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Down - What's Next?

Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Down - Time to Sell...

Iqbal Hussain Sells 38,951 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) insider Iqbal Hussain sold 38,951 shares of the stock in a transaction on Monday, February 2nd. The stock was sold at an...

Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 1,010 Shares of Stock

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) insider Iqbal Hussain sold 1,010 shares of the company's stock in a transaction that occurred on Friday, January 30th. The...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of "Moderate Buy" from Analysts

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) has earned an average rating of "Moderate Buy" from the thirteen analysts that are currently covering the firm, Marketbeat...

Truist Financial Forecasts Strong Price Appreciation for Centessa Pharmaceuticals (NASDAQ:CNTA) Stock

Truist Financial boosted their price objective on shares of Centessa Pharmaceuticals from $33.00 to $38.00 and gave the company a "buy" rating in a research note on Thursday...

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Strong Trading Volume - Time to Buy?

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Unusually-High Trading Volume - Here's Why...

Truist Financial increased their price objective on Centessa Pharmaceuticals from $30.00 to $33.00 and gave the company a "buy" rating in a research report on Thursday...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of "Moderate Buy" by Brokerages

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) has received an average rating of "Moderate Buy" from the twelve ratings firms that are presently covering the company...

Centessa Pharmaceuticals' (CNTA) "Buy" Rating Reiterated at Chardan Capital

Chardan Capital restated a "buy" rating and issued a $30.00 target price on shares of Centessa Pharmaceuticals in a report on Friday...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Analysts

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) has been assigned an average recommendation of "Buy" from the thirteen analysts that are currently covering the firm...

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Centessa Pharmaceuticals plc - ADR

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

CNTA
Centessa Pharmaceuticals PLC - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CNTA News

CNTACentessa Pharmaceuticals PLC - ADR